Takeover of XenoPort, Inc. (NASDAQ:XNPT) Under Investigation for Investors Concerning Potential Wrongdoing
The takeover of XenoPort, Inc. is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:XNPT shares, concerning whether the takeover of XenoPort, Inc. by Arbor Pharmaceuticals, LLC for $7.03 per share is unfair.
View full press release